Hormonal Antiandrogen Acne Treatment (HAAT) is not typically used as a first-line systemic therapy in women with acne reported as p recent study published in American journal of clinical dermatology. A recent retrospective study which aimed to identify dermatologists’ HAAT-prescribing behaviors and its impact on antibiotic use in women with acne reported that HAAT is not typically used as a first-line therapy in women with acne. Furthermore, study suggests that among the all available medications for acne, antibiotics were used as first-line treatment in 39% of patients, combined oral contraceptives in 12%, and spironolactone in 21%.
Likewise, the study reveals that HAAT use showed significant inverse correlation with mean antibiotic duration (p = 0.016). Source: Park JH, Bienenfeld A, Orlow SJ, Nagler AR. The Use of Hormonal Antiandrogen Therapy in Female Patients with Acne: A 10-Year…
